The Patent Finder

Terms ending in 2035

Yeda Research and Development Co. Ltd.

Every in-force patent on Yeda Research and Development Co. Ltd.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,066,014Anti CD84 Antibodies, Compositions Comprising Same and Uses Thereof
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 10,125,365Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 10,611,839Anti CD84 Antibodies, Compositions Comprising Same and Uses Thereof
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In forceMedium confidence
US 10,975,373Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In forceMedium confidence
US 11,680,263Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In forceMedium confidence
US 10,053,712Use of Enzymes Which Catalyze Pyruvate Synthesis from Formate and Acetyl-Coa and Bacteria Expressing Same
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 9,815,757Preparation of Aldehydes and Ketones from Alkenes Using Polyoxometalate Catalysts and Nitrogen Oxides
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 9,394,365Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 9,512,225Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 9,512,227Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co., Ltd.In forceHigh confidence
37 more term ends in 2035 · Pro
10 of 47 patents shown. Soonest term end first, then patent number.
Pro members see all 47.
Upgrade to Pro
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited